Table 1.
The clinical information of the 104 COVID-19 patients.
| Items | Sub-items | Case distribution (104) | Common (50) | Severe (29) | Critical (25) | df | P |
|---|---|---|---|---|---|---|---|
| Age (years) | Median | 62.82 (14.77) | 58.10 (14.82) | 65.86 (14.94) | 68.72 (11.54) | 5.629 | 0.005 |
| ≥60 | 69 (66.35%) | 27 (39.13%) | 21 (30.43%) | 21 (30.43%) | 7.381 | 0.025 | |
| Gender | Male | 53 (50.96%) | 23 (46.00%) | 13 (44.83%) | 17 (68.00%) | 3.833 | 0.147 |
| Female | 51 (49.04%) | 27 (54.00%) | 16 (55.17%) | 8 (32.00%) | |||
| Comorbidity | 45 (49.21%) | 8 (16%) | 16 (55.17%) | 21 (84.00%) | 33.717 | <0.0001 | |
| High blood pressure | 28 (26.92%) | 2 (4%) | 9 (31.03%) | 17(68.00%) | 35.043 | <0.0001 | |
| Diabetes mellitus | 16 (15.38%) | 4 (8%) | 7 (24.14%) | 5 (20.00%) | 4.211 | 0.122 | |
| Chronic obstructive pulmonary disease | 5 (4.81%) | 2 (4.0%) | 1 (3.45%) | 2 (8.80%) | 0.689 | 0.745 | |
| Coronary heart disease | 8 (7.69%) | 1 (2.00%) | 3 (10.34%) | 4 (16.00%) | 4.999 | 0.082 | |
| Cerebrovascular diseases | 5 (4.81%) | 1 (2.00%) | 1 (3.45%) | 3 (12.00%) | 3.804 | 0.149 | |
| Oxygen saturation (%) | 94.42 ± 5.50 | 97.10 ± 1.594 | 93.03 ± 5.302 | 90.68 ± 7.734 | 16.450 | <0.0001 | |
| Primary leukocyte count | 7.20 ± 3.81 | 5.75 ± 1.56 | 7.19 ± 2.50 | 10.10 ± 6.07 | 13.481 | <0.0001 | |
| Primary lymphocyte count | 1.29 ± 0.70 | 1.56 ± 0.61 | 1.09 ± 0.50 | 0.95 ± 0.84 | 9.141 | <0.0001 | |
| Primary albumin | 34.96 ± 5.57 | 36.72 ± 4.22 | 35.77 ± 5.14 | 30.48 ± 6.15 | 13.519 | <0.0001 | |
| Primary C-reactive protein | 41.71 ± 53.00 | 13.71 ± 21.02 | 33.04 ± 32.78 | 107.78 ± 60.23 | 54.76 | <0.0001 | |
| Primary IL-6 | 87.85 ± 516.25 | 9.65 ± 31.07 | 12.02 ± 14.99 | 304.16 ± 987.83 | 3.112 | 0.049 | |
| Primary D-dimer | 3.28 ± 5.63 | 0.91 ± 1.63 | 2.42 ± 3.42 | 9.01 ± 8.38 | 26.448 | <0.0001 |